Prospective Pecutaneous Coronary Intervention Registry

Coronary Artery Disease Clinical Trial

— SMC-PCI  

Official title:

Prospective Registry for Identifying Long-term Prognosis in Patients Who Underwent Coronary Angiography and Percutaneous Coronary Intervention for Coronary Artery Disease

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05624905
• Other study ID #: SMC-PCI
• Status: Recruiting
• Start date: March 20, 2016
• Est. completion date: December 31, 2030

Study information

• Verified date: November 2022
• Source: Samsung Medical Center
• Contact: Joo-Yong Hahn, MD
• Phone: 82-2-3410-3419
• Email: jyhahn[@]skku.edu
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

Coronary artery disease is the most important cause of death worldwide. Treatment option for coronary artery disease is medical treatment, percutaneous coronary intervention, or coronary artery bypass surgery. Among them, the field of percutaneous coronary intervention is rapidly developing with regard to the improvement of devices, techniques, or medical treatment, leading to reduce mortality or morbidity. Until now, numerous previous studies related to the risk factors of coronary artery disease and the prognosis of patients have been conducted. However, the field of percutaneous coronary intervention is rapidly evolving, and treatment strategies are constantly being updated. Therefore, the current study sought to identify the long-term prognosis and related risk factors of patients with coronary artery disease who underwent percutaneous coronary intervention.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 15000
• Est. completion date: December 31, 2030
• Est. primary completion date: December 31, 2030
• Accepts healthy volunteers: No
• Gender: All
• Age group: 19 Years and older

Eligibility

Inclusion Criteria:

• patients who have undergone or are scheduled to undergo coronary angiography and percutaneous coronary intervention.

Exclusion Criteria:

• patients who did not consent to the research

Related Conditions & MeSH terms

• Coronary Artery Disease
• Coronary Disease
• Myocardial Ischemia
• Percutaneous Coronary Intervention

Intervention

Procedure:
• Percutaneous coronary intervention
Percutaneous Coronary Intervention Procedure

Locations

Country	Name	City	State
Korea, Republic of	Samsung Medical Center	Seoul

Sponsors (1)

Lead Sponsor	Collaborator
Samsung Medical Center

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Rates of Cardiac death or Target-vessel myocardial infarction	A composite of cardiac death or target vessel myocardial infarction	up to 10 years
Primary	Rates of Major adverse cardiac and cerebrovascular event	A composite of all-cause death, myocardial infarction, cerebrovascular accident, or repeat revascularization	up to 10 years
Secondary	Rates of all-cause death	Death from any cause	up to 10 years
Secondary	Rates of cardiac death	Death from cardiac cause	up to 10 years
Secondary	Rates of myocardial infarction	Any myocardial infarction	up to 10 years
Secondary	Rates of target-vessel myocardial infarction	target-vessel myocardial infarction	up to 10 years
Secondary	Rates of target lesion revascularization	target lesion revascularization	up to 10 years
Secondary	Rates of target vessel revascularization	target vessel revascularization	up to 10 years
Secondary	Rates of cerebrovascular accident	ischemic or hemorrhagic stroke	up to 10 years
Secondary	Rates of stent thrombosis	definite or probable stent thrombosis	up to 10 years